Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1971 1
1993 1
1994 1
1995 1
1997 1
1998 1
1999 1
2000 3
2001 3
2006 2
2007 1
2008 2
2009 2
2010 3
2011 1
2013 2
2014 1
2017 1
2018 2
2020 6
2021 1
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

37 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Sirabahenda
Page 1
[Minocycline].
D'Aoust P, Noreau G, Rochette C, Zacharie J, Landry RG. D'Aoust P, et al. J Can Dent Assoc. 1993 Jul;59(7):619-22, 624. J Can Dent Assoc. 1993. PMID: 8334557 Review. French.
Hidden proteome of synaptic vesicles in the mammalian brain.
Taoufiq Z, Ninov M, Villar-Briones A, Wang HY, Sasaki T, Roy MC, Beauchain F, Mori Y, Yoshida T, Takamori S, Jahn R, Takahashi T. Taoufiq Z, et al. Proc Natl Acad Sci U S A. 2020 Dec 29;117(52):33586-33596. doi: 10.1073/pnas.2011870117. Epub 2020 Dec 21. Proc Natl Acad Sci U S A. 2020. PMID: 33376223 Free PMC article.
Synergistic anti-tumor activity of a novel immunomodulator, BCH-1393, in combination with cyclophosphamide.
Kadhim S, Penney C, Lagraoui M, Heibein J, Attardo G, Zacharie B, Connolly T, Gagnon L. Kadhim S, et al. Int J Immunopharmacol. 2000 Sep;22(9):659-71. doi: 10.1016/s0192-0561(00)00028-x. Int J Immunopharmacol. 2000. PMID: 10884587
N,N-dimethylaminopurine pentoxycarbonyl D-arginine (BCH-1393) is a novel low molecular weight synthetic immunomodulator that has been shown to significantly stimulate cytotoxic T-lymphocyte responses both in vitro and in vivo (Zacharie B, Gagnon L, Attardo G, Connolly TP, …
N,N-dimethylaminopurine pentoxycarbonyl D-arginine (BCH-1393) is a novel low molecular weight synthetic immunomodulator that has been shown …
Fatty acid mimetic PBI-4547 restores metabolic homeostasis via GPR84 in mice with non-alcoholic fatty liver disease.
Simard JC, Thibodeau JF, Leduc M, Tremblay M, Laverdure A, Sarra-Bournet F, Gagnon W, Ouboudinar J, Gervais L, Felton A, Letourneau S, Geerts L, Cloutier MP, Hince K, Corpuz R, Blais A, Quintela VM, Duceppe JS, Abbott SD, Blais A, Zacharie B, Laurin P, Laplante SR, Kennedy CRJ, Hébert RL, Leblond FA, Grouix B, Gagnon L. Simard JC, et al. Sci Rep. 2020 Jul 29;10(1):12778. doi: 10.1038/s41598-020-69675-8. Sci Rep. 2020. PMID: 32728158 Free PMC article.
Immunostimulant oxidized beta-glucan conjugates.
Cross GG, Jennings HJ, Whitfield DM, Penney CL, Zacharie B, Gagnon L. Cross GG, et al. Int Immunopharmacol. 2001 Mar;1(3):539-50. doi: 10.1016/s1567-5769(00)00021-7. Int Immunopharmacol. 2001. PMID: 11367537
37 results